These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cyanobacteria, neurotoxins and water resources: are there implications for human neurodegenerative disease? Metcalf JS; Codd GA Amyotroph Lateral Scler; 2009; 10 Suppl 2():74-8. PubMed ID: 19929737 [TBL] [Abstract][Full Text] [Related]
5. The emerging science of BMAA: do cyanobacteria contribute to neurodegenerative disease? Holtcamp W Environ Health Perspect; 2012 Mar; 120(3):A110-6. PubMed ID: 22382274 [No Abstract] [Full Text] [Related]
6. Possible therapy for ALS based on the cyanobacteria/BMAA hypothesis. Bradley WG Amyotroph Lateral Scler; 2009; 10 Suppl 2():118-23. PubMed ID: 19929743 [TBL] [Abstract][Full Text] [Related]
7. The Potential Role of BMAA in Neurodegeneration. Caller T; Henegan P; Stommel E Neurotox Res; 2018 Jan; 33(1):222-226. PubMed ID: 28612294 [TBL] [Abstract][Full Text] [Related]
8. β-N-Methylamino-L-alanine (BMAA) uptake by the aquatic macrophyte Ceratophyllum demersum. Esterhuizen M; Pflugmacher S; Downing TG Ecotoxicol Environ Saf; 2011 Jan; 74(1):74-7. PubMed ID: 20447690 [TBL] [Abstract][Full Text] [Related]
9. Human exposure to cyanobacteria and BMAA. Brand LE Amyotroph Lateral Scler; 2009; 10 Suppl 2():85-95. PubMed ID: 19929739 [TBL] [Abstract][Full Text] [Related]
10. Three phases of research on beta-N-methylamino-L-alanine (BMAA)--a neurotoxic amino acid. Nunn PB Amyotroph Lateral Scler; 2009; 10 Suppl 2():26-33. PubMed ID: 19929728 [TBL] [Abstract][Full Text] [Related]
11. Vervets and macaques: Similarities and differences in their responses to l-BMAA. Spencer PS; Garner CE; Palmer VS; Kisby GE Neurotoxicology; 2016 Sep; 56():284-286. PubMed ID: 27032904 [No Abstract] [Full Text] [Related]
12. Synergistic toxicity of the environmental neurotoxins methylmercury and β-N-methylamino-L-alanine. Rush T; Liu X; Lobner D Neuroreport; 2012 Mar; 23(4):216-9. PubMed ID: 22314682 [TBL] [Abstract][Full Text] [Related]
13. beta-N-methylamino-l-alanine induces oxidative stress and glutamate release through action on system Xc(-). Liu X; Rush T; Zapata J; Lobner D Exp Neurol; 2009 Jun; 217(2):429-33. PubMed ID: 19374900 [TBL] [Abstract][Full Text] [Related]
14. Why does Finland have the highest dementia mortality rate? Environmental factors may be generalizable. Eiser AR Brain Res; 2017 Sep; 1671():14-17. PubMed ID: 28687259 [TBL] [Abstract][Full Text] [Related]
15. Detection of the neurotoxin BMAA within cyanobacteria isolated from freshwater in China. Li A; Tian Z; Li J; Yu R; Banack SA; Wang Z Toxicon; 2010 May; 55(5):947-53. PubMed ID: 19822166 [TBL] [Abstract][Full Text] [Related]
16. Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration? The beta-N-methylamino-L-alanine (BMAA) paradigm. Papapetropoulos S Neurochem Int; 2007 Jun; 50(7-8):998-1003. PubMed ID: 17296249 [TBL] [Abstract][Full Text] [Related]
17. Diverse taxa of cyanobacteria produce beta-N-methylamino-L-alanine, a neurotoxic amino acid. Cox PA; Banack SA; Murch SJ; Rasmussen U; Tien G; Bidigare RR; Metcalf JS; Morrison LF; Codd GA; Bergman B Proc Natl Acad Sci U S A; 2005 Apr; 102(14):5074-8. PubMed ID: 15809446 [TBL] [Abstract][Full Text] [Related]
18. Environmental hypothesis for brain diseases strengthened by new data. Lewin R Science; 1987 Jul; 237(4814):483-4. PubMed ID: 3603034 [No Abstract] [Full Text] [Related]
19. Is exposure to cyanobacteria an environmental risk factor for amyotrophic lateral sclerosis and other neurodegenerative diseases? Bradley WG; Borenstein AR; Nelson LM; Codd GA; Rosen BH; Stommel EW; Cox PA Amyotroph Lateral Scler Frontotemporal Degener; 2013 Sep; 14(5-6):325-33. PubMed ID: 23286757 [TBL] [Abstract][Full Text] [Related]
20. Animal models of BMAA neurotoxicity: a critical review. Karamyan VT; Speth RC Life Sci; 2008 Jan; 82(5-6):233-46. PubMed ID: 18191417 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]